Bioregenx (BRGX) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
BIOREGENX, INC.  (OTC: BRGX)

Select the Financial Report: Select the Period:


Description of Bioregenx's Business Segments


The Company operates in a single reportable segment, consolidating all material operating units due to their similar customer base, economic characteristics, product and service nature, and procurement, manufacturing, and distribution processes. This segment includes finished goods inventories in medical testing, wellness devices, and nutritional products. Medical testing equipment components are purchased and assembled upon order and may be sold separately. Nutritional inventories are purchased as finished products with labels applied separately to support production runs. The Company acquired DocSun Biomedical Holdings, Inc., which provides medical diagnostic technology that complements and expands its product offerings.




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.